Abstract:This schematic illustrates the multimodality imaging approach to aortic stenosis management, showcasing the interconnected processes of diagnosis, prognosis, and optimal timing for aortic valve replacement, and underscoring the synergy between different diagnostic techniques and their collective impact on clinical decision‐making for patients with moderate aortic stenosis. Created with Biorender.com Abbreviations: AS, aortic stenosis; AR, aortic regurgitation; AVR, aortic valve replacement; CMR, cardiovascular magnetic resonance; CT, computed tomography; DTI, diffusion tensor imaging; GLS, global longitudinal strain; LGE, late gadolinium enhancement; LV, left ventricle; LVEF, left ventricular ejection fraction. Aortic stenosis (AS) stands as the most common valvular heart disease in developed countries and is characterized by progressive narrowing of the aortic valve orifice resulting in elevated transvalvular flow resistance, left ventricular hypertrophy, and progressive increased risk of heart failure and sudden death. This narrative review explores clinical challenges and evolving perspectives in moderate AS, where discrepancies between aortic valve area and pressure gradient measurements may pose diagnostic and therapeutic quandaries. Transthoracic echocardiography is the first‐line imaging modality for AS evaluation, yet cases of discordance may require the application of ancillary noninvasive diagnostic modalities. This review underscores the importance of accurate grading of AS severity, especially in low‐gradient phenotypes, emphasizing the need for vigilant follow‐up. Current clinical guidelines primarily recommend aortic valve replacement for severe AS, potentially overlooking latent risks in moderate disease stages. The noninvasive multimodality imaging approach—including echocardiography, cardiac magnetic resonance, computed tomography, and nuclear techniques—provides unique insights into adaptive and maladaptive cardiac remodeling in AS and offers a promising avenue to deliver precise indications and exact timing for intervention in moderate AS phenotypes and asymptomatic patients, potentially improving long‐term outcomes. Nevertheless, what we may have gleaned from a large amount of observational data is still insufficient to build a robust framework for clinical decision‐making in moderate AS. Future research will prioritize randomized clinical trials designed to weigh the benefits and risks of preemptive aortic valve replacement in the management of moderate AS, as directed by specific imaging and nonimaging biomarkers.

Diagnosis and management of aortic valve stenosis in patients with heart failure

Aortic Stenosis, Heart Failure, and Aortic Valve Replacement

Diagnostic Challenges in Aortic Stenosis

Comprehensive assessment of the aortic valve in critically ill patients for the non-cardiologist. Part I: Aortic stenosis of the native valve

Moderate aortic stenosis: Navigating the uncharted

Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long‐Term Registry

Multimodality Imaging for the Global Evaluation of Aortic Stenosis: the Valve, the Ventricle, the Afterload

Recent Updates on Asymptomatic and Symptomatic Aortic Valve Stenosis its Diagnosis, Pathogenesis, Management and Future perspectives

Moderate Aortic Stenosis-Advanced Imaging, Risk Assessment, and Treatment Strategies

ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis

Impact of selected comorbidities on the presentation and management of aortic stenosis

Impact of Stress Echocardiography on Aortic Valve Stenosis Management

Asymptomatic Aortic Stenosis: From Risk Stratification to Treatment

From the Pathophysiology to the Intervention, Current Challenges, and Future Perspectives

[Catheter-based and surgical treatment for aortic valve diseases]

Prevalence and prognosis of aortic valve diseases in patients hospitalized with heart failure with mildly reduced ejection fraction

Structural heart disease review of TAVR in low-risk patients: importance of lifetime management

Challenges in Diagnosis and Functional Assessment of Coronary Artery Disease in Patients With Severe Aortic Stenosis

Impact of Moderate Aortic Stenosis in Patients With Heart Failure With Reduced Ejection Fraction

A Comprehensive Geriatric Workup and Frailty Assessment in Older Patients with Severe Aortic Stenosis

Current Management and Therapy of Severe Aortic Stenosis and Future Perspective